Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-operative Octreotide LAR in Acromegaly Pituitary Macroadenoma Surgery
2005-003496-20Phase 4Completed
- Sponsor
- Oxford University Hospitals
- Start
- Oct 2006
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of octreotide in acromegaly (2 arms), sponsored by Oxford University Hospitals. Primary endpoint: Surgical cure rate. Started Oct 2006; status: completed.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2005-003496-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003496-20.